Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00492284Phase 2Completed
Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)
Choroidal NeovascularizationMacular Degeneration
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Retina Diagnostic & Treatment Associates, LLC

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Oscar Cuzzani, MD

QLT Inc.

Related
5 trials

Shared therapeutic areas:

Choroidal NeovascularizationMacular Degeneration

Worked with same sponsors:

QLT Inc.
Collaborated on 1 trial
Similarity Score24%

Andrew Strong, Ph.D

QLT Inc.

Related
1 trials

Shared therapeutic areas:

Choroidal NeovascularizationMacular Degeneration

Worked with same sponsors:

QLT Inc.
Collaborated on 1 trial
Similarity Score24%

Henry Hudson, MD

Retina Centers, PC

Related
1 trials

Shared therapeutic areas:

Choroidal NeovascularizationMacular Degeneration

Worked with same sponsors:

QLT Inc.
Collaborated on 1 trial
Similarity Score24%

Steven Rose, MD

Retina Associates of Western New York

Related
1 trials

Shared therapeutic areas:

Macular Degeneration
Similarity Score15%

Gerhard Garhöfer, MD

Department of Clinical Pharmacology, Medical University of Vienna

Related
10 trials

Shared therapeutic areas:

Macular Degeneration
Similarity Score15%

Adriana Solís-Vivanco, MD

Asociación para Evitar la Ceguera en México

Related
2 trials

Shared therapeutic areas:

Choroidal Neovascularization
Similarity Score15%

Griselda Alvarez-Rivera, MD

Asociación para Evitar la Ceguera en México

Related
2 trials

Shared therapeutic areas:

Choroidal Neovascularization
Similarity Score15%

Veronica Kon-Jara, MD

Asociación para Evitar la Ceguera en México

Related
4 trials

Shared therapeutic areas:

Choroidal Neovascularization
Similarity Score15%

Glenn Stoller, MD

Ophthalmic Consultants of Long Island

Related
1 trials

Shared therapeutic areas:

Macular Degeneration
Similarity Score15%

Alcon Investigators

Alcon Research

Related
5 trials

Shared therapeutic areas:

Macular Degeneration
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00492284Phase 2PrincipalInvestigator

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

Choroidal NeovascularizationMacular Degeneration
Completed

All 1 trials loaded